# | ||||
---|---|---|---|---|
1 | REACTION Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans | 2014 | 2˙755˙719.00 | 2˙575˙809.00 |
2 | EBOVAC2 Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861 | 2014 | 50˙710˙893.00 | 22˙790˙820.00 |
3 | CANNAPREG Development of pregnenolone derivatives as allosteric inhibitors of CB1 cannabinoid receptors for the treatment of schizophrenia and psychotic syndromes | 2015 | 150˙000.00 | 150˙000.00 |
4 | JPCO-FUND ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 | 2015 | 30˙953˙030.00 | 9˙999˙999.00 |
5 | CORTICALS Amyotrophic Lateral Sclerosis from a cortical perspective: towards alternative therapeutic strategies | 2015 | 1˙500˙000.00 | 1˙500˙000.00 |
6 | GABACODEV Role of GABAergic microcircuits with different embryonic origins in the orchestration of early cortical dynamics in the awake mouse pup | 2015 | 173˙076.00 | 173˙076.00 |
7 | CHAT Control of the Homeostasis of Actin through Time: actin homeostasis during embryonic development by means of single-molecule imaging and simulation in C. elegans | 2015 | 185˙076.00 | 185˙076.00 |
8 | CLOPRESS Renal Chloride Chanels and Blood Pressure Regulation | 2015 | 173˙076.00 | 173˙076.00 |
9 | COMPUCELL Autonomous Cellular Computers for Diagnosis | 2015 | 1˙500˙000.00 | 1˙500˙000.00 |
10 | RISTRAD Risk Stratification for Sudden Cardiac Death | 2015 | 173˙076.00 | 173˙076.00 |
11 | ENSAT-HT Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension | 2015 | 8˙440˙635.00 | 7˙607˙337.00 |
12 | ADIPOR Molecular and structural pharmacology of adiponectin receptor: towards innovative treatments of obesity-related diseases. | 2015 | 1˙989˙518.00 | 1˙989˙518.00 |
13 | MOBILISENSE Air pollution and noise exposure related to personal transport behaviour: short-term and longer-term effects on health | 2015 | 2˙000˙000.00 | 2˙000˙000.00 |
14 | ID4 Role of Id4 in the adult subventricular zone of normal and injured brain | 2015 | 173˙076.00 | 173˙076.00 |
15 | BRAIN MICRO SNOOPER A mimetic implant for low perturbation, stable stimulation and recording of neural units inside the brain. | 2015 | 1˙499˙850.00 | 1˙499˙850.00 |
16 | SHIPS Screening to improve Health In very Preterm infantS in Europe | 2015 | 2˙993˙175.00 | 2˙993˙174.00 |
17 | CHEMREPEAT Structure and Dynamics of Low-Complexity Regions in Proteins: The Huntingtin Case | 2015 | 1˙999˙844.00 | 1˙999˙844.00 |
18 | ALLERGYBLOCK Blocking peanut allergy through protective IgG antibodies | 2015 | 185˙076.00 | 185˙076.00 |
19 | ACTINIT Brain-behavior forecasting: The causal determinants of spontaneous self-initiated action in the study of volition and the development of asynchronous brain-computer interfaces. | 2015 | 1˙338˙130.00 | 1˙338˙130.00 |
20 | NEURIMMUNE Neural regulation of immunity | 2015 | 2˙000˙000.00 | 2˙000˙000.00 |
21 | NEUROPIONEERS A developmental engram for the organization of adult hippocampal circuits | 2015 | 1˙996˙947.00 | 1˙996˙947.00 |
22 | TANYFEEDNEURONS Gliotransmission and shuttling of metabolic signals to feeding neuronal circuits by tanycytes | 2015 | 185˙076.00 | 185˙076.00 |
23 | ELASTOCARDIOSCOPE An innovative tool for non-invasive evaluation of myocardial stiffness | 2015 | 149˙750.00 | 149˙750.00 |
24 | JPSUSTAIND Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases | 2015 | 2˙043˙283.00 | 2˙043˙283.00 |
25 | LYMPHOSIGN Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma | 2015 | 200˙119.00 | 200˙119.00 |
26 | EDEN Ependymal cell Development: New insight into neurological diseases | 2015 | 1˙999˙484.00 | 1˙999˙484.00 |
27 | ERINHA2 European Research Infrastructure on Highly Pathogenic Agents 2 | 2016 | 1˙443˙927.00 | 1˙443˙927.00 |
28 | HEPCIR Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 | 2˙305˙000.00 | 2˙305˙000.00 |
29 | MECHANOFATE From mechanical stress to vascular fate | 2016 | 1˙498˙412.00 | 1˙498˙412.00 |
30 | PRETREAT PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform | 2016 | 387˙000.00 | 387˙000.00 |
31 | MEDIT-AGEING Investigating the impact of meditation training on mental health and wellbeing in the ageing population | 2016 | 7˙087˙230.00 | 6˙134˙756.00 |
32 | SAFEIMMUNOSUPPRESS Development of immunosuppressive treatments with better safety | 2016 | 150˙000.00 | 150˙000.00 |
33 | EHVA European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | 2016 | 28˙135˙596.00 | 22˙188˙521.00 |
34 | PREG-LAB Distinctive characterization of regulatory plasma cells and pro-inflammatory B cells in immunity: their origins, molecular properties, and cellular fates. | 2016 | 1˙999˙375.00 | 1˙999˙375.00 |
35 | MINERVA Micro-RNAs of neutrophils in renal ANCA-associated vasculitis | 2016 | 173˙076.00 | 173˙076.00 |
36 | OPTONMDA Optical strategies to investigate NMDA receptor functional diversity and its therapeutic potential | 2016 | 185˙076.00 | 185˙076.00 |
37 | ICARO Ion Channels and Receptors Operation | 2016 | 173˙076.00 | 173˙076.00 |
38 | CD4DNASP Cell intrinsic control of CD4 T cell differentiation by cytosolic DNA sensing pathways | 2016 | 1˙500˙000.00 | 1˙500˙000.00 |
39 | ILC_REACTIVITY Biological Determinants of ILC Reactivity for Immune Responses in Health and Disease | 2016 | 1˙899˙375.00 | 1˙899˙375.00 |
40 | COBABATI Cofactor Binding Antibodies – Basic Aspects and Therapeutic Innovations | 2016 | 1˙255˙000.00 | 1˙255˙000.00 |
41 | B-RESPONSE Memory and innate-like B-cell subsets: deciphering a multi-layered B-cell response in mice and humans | 2016 | 2˙098˙750.00 | 2˙098˙750.00 |
42 | SEMA3C Genetic dissection of the SEMA3C/Neuropilin 1 signalling pathway in Chronic Kidney Disease progression | 2016 | 185˙076.00 | 185˙076.00 |
43 | PTOACONS Going from Phenomenal to Access Consciousness: Neurobehavioural correlates of visual consciousness development and its underlying cognitive procesess. | 2016 | 173˙076.00 | 173˙076.00 |
44 | ZIKALLIANCE A global alliance for Zika virus control and prevention | 2016 | 15˙684˙925.00 | 11˙964˙209.00 |
45 | EPITOR NEUROBIOLOGY OF EPILEPSY GENES | 2016 | 1˙998˙760.00 | 1˙998˙760.00 |
46 | GENE FOR CURE Expanding and extending gene therapy of monogenic diseases of the haematopoietic system | 2016 | 2˙445˙267.00 | 2˙445˙267.00 |
47 | NMDADYN NMDA receptor diversity: from molecular dynamics to synaptic physiopathology | 2016 | 2˙500˙000.00 | 2˙500˙000.00 |
48 | MIDOC Multimodal Imaging of Disorders of Consciousness | 2016 | 185˙076.00 | 185˙076.00 |
49 | PANDORA Platelets: at the nexus of brain aneurysm | 2016 | 173˙076.00 | 173˙076.00 |
50 | DYNAMATT Dynamics of Attentional Networks in the Human Brain in Health and Disease: Evidence from Intracerebral and MEG Recordings | 2017 | 185˙076.00 | 185˙076.00 |
51 | VITRUVIUS The Genetics and Physiology of Growth and Size Determination | 2017 | 2˙499˙144.00 | 2˙499˙144.00 |
52 | BRAINDYN Tracking information flow in the brain: A unified and general framework for dynamic communication in brain networks | 2017 | 1˙333˙718.00 | 1˙333˙718.00 |
53 | ROSALIND Investigating fibROmuscular dysplasia and spontaneous coronary Artery dissection using genetic and functionaL genomics to decipher the origIN of two female specific cardiovascular Diseases | 2017 | 1˙500˙000.00 | 1˙500˙000.00 |
54 | INSTANTSCOPE Development of high-resolution, high-throughput microscopy | 2017 | 149˙788.00 | 149˙788.00 |
55 | PARAGEN Biomaterials with incorporated MSC-secreted PARAcrine molecules for bone reGENeration | 2017 | 246˙668.00 | 246˙668.00 |
56 | ALS-NETWORKS Defining functional networks of genetic causes for ALS and related neurodegenerative disorders | 2017 | 2˙000˙000.00 | 2˙000˙000.00 |
57 | PROGLUTASIS Protection of cardiometabolic inflammation by modulation of myeloid glutamine homeostasis | 2017 | 2˙091˙338.00 | 2˙091˙338.00 |
58 | REG-SEQ Functional genomics of non-coding mutations in regulatory regions of four metabolic tissues, and their involvement into type 2 diabetes through large-scale sequencing | 2017 | 1˙500˙000.00 | 1˙500˙000.00 |
59 | REPRODAMH Extra-gonadal roles of Anti-Müllerian Hormone in the aetiology of polycystic ovary syndrome: the domino effect to reproductive neuroendocrine dysfunctions | 2017 | 1˙999˙740.00 | 1˙999˙740.00 |
60 | NANOVOLTSENS Voltage-sensing nanorods for super-resolution voltage imaging in neurons | 2017 | 185˙076.00 | 185˙076.00 |
61 | INVESTIGERFE Investigating the regulation of iron homeostasis by erythroferrone and therapeutic applications | 2017 | 1˙499˙235.00 | 1˙499˙235.00 |
62 | SPONTANEOUS ZEBRAIN Whole-brain dynamics underlying self-generated behaviour | 2017 | 1˙997˙360.00 | 1˙997˙360.00 |
63 | PRELICAN Treatment of liver disease and cancer prevention | 2017 | 150˙000.00 | 150˙000.00 |
64 | CETACEAN INNER EAR Cetacean Inner Ear | 2017 | 185˙076.00 | 185˙076.00 |
65 | NASCENTOMIX Ribosome inhibition by nascent or antimicrobial peptides | 2017 | 1˙999˙125.00 | 1˙999˙125.00 |
66 | EPIFAT Epigenomic Reprogramming of Adipose Tissue Function and Energy Metabolism in Type 2 Diabetes | 2017 | 2˙000˙000.00 | 2˙000˙000.00 |
67 | METACHROM Establishment and maintenance of gene expression by heterochromatin factors | 2017 | 1˙999˙025.00 | 1˙999˙025.00 |
68 | NEUCOSE The neural correlates of the self in altered states of consciousness. | 2017 | 185˙076.00 | 185˙076.00 |
69 | NEMESIS Neuron/mast cell interactions in skin diseases | 2017 | 185˙076.00 | 185˙076.00 |
70 | DISTRICT DECIPHERING THE ROLE OF TRIB1 IN REGULATORY T CELLS | 2017 | 185˙076.00 | 185˙076.00 |
71 | ANTIVIR Molecular mechanisms of interferon-induced antiviral restriction and signalling | 2017 | 1˙499˙793.00 | 1˙499˙793.00 |
72 | R-LINK Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative | 2018 | 7˙808˙072.00 | 7˙702˙532.00 |
73 | MAXIBONE Personalised maxillofacial bone regeneration | 2018 | 5˙975˙915.00 | 5˙949˙665.00 |
74 | RONDBIOCAN NLRP3 in cancer: Deciphering the role of NLRP3 in the DNA Damage response pathway | 2018 | 173˙076.00 | 173˙076.00 |
75 | TRANSTRYP Structural differences in mRNA translation machineries between eukaryotic pathogens and their mammalian hosts | 2018 | 1˙787˙400.00 | 1˙787˙400.00 |
76 | EU-TRAIN The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients | 2018 | 6˙641˙546.00 | 6˙641˙546.00 |
77 | ENLIGHTEN INTEGRATION AND PROPAGATION OF IMMUNOLOGICAL SIGNALS DURING CANCER AND INFECTION | 2018 | 2˙499˙994.00 | 2˙499˙994.00 |
78 | BRAVEST Boosting Reward-based Attention through VEstibular STimulation | 2018 | 173˙076.00 | 173˙076.00 |
79 | DRIVE GUIDANCE AND FUNCTION OF REGENERATIVE FIBERS IN ADULT CNS | 2018 | 1˙499˙410.00 | 1˙499˙410.00 |
80 | ALTCHEM In vivo functional screens to decipher mechanisms of stochastically- and mutationally-induced chemoresistance in Acute Myeloid Leukemia | 2018 | 1˙500˙000.00 | 1˙500˙000.00 |
81 | SYNPCP Synapse formation and maturity through planar cell polarity pathway | 2018 | 173˙076.00 | 173˙076.00 |
82 | NEUROREMOD Mechanisms of neuronal network remodeling in the adult mammalian brain | 2018 | 1˙493˙750.00 | 1˙493˙750.00 |
83 | EXCITATOR Active probing of brain excitability by electrical micro-stimulations for drug discovery | 2018 | 150˙000.00 | 150˙000.00 |
84 | IMMUNAID Immunome project consortium for AutoInflammatory Disorders | 2018 | 15˙835˙851.00 | 15˙835˙851.00 |
85 | OPTIMIZERR Errors as cost-optimizing decisions? Redefining the origin and nature of human decision errors in light of associated neural computations | 2018 | 1˙497˙125.00 | 1˙497˙125.00 |
86 | CXCR4THERAPY IMPROVING HEMATOPOIETIC STEM CELL- BASED GENE THERAPY OUTCOME BY MODULATING CXCR4 EXPRESSION | 2018 | 173˙076.00 | 173˙076.00 |
87 | CROWDASSAY Folding Pathways of DNA G-quadruplexes in Crowding Conditions, and Implications for Mass Spectrometry-based Ligand Screening Assays | 2018 | 173˙076.00 | 173˙076.00 |
88 | DAMOCLES Modelling brain aneurysm to elucidate the role of platelets | 2018 | 1˙498˙618.00 | 1˙498˙618.00 |
89 | PBIOSTRAT-FOR-PDA Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management | 2018 | 150˙000.00 | 150˙000.00 |
90 | STARNEL supracellular contractility of myofibroblasts in gut homeostasis and cancer invasion | 2018 | 2˙000˙000.00 | 2˙000˙000.00 |
91 | HUMAN TEXTILES Human, Woven, Tissue-Engineered Blood Vessels (TEBV) Exclusively from Cell-Assembled Extracellular Matrix (CAM). | 2018 | 2˙491˙543.00 | 2˙491˙543.00 |
92 | MICABRA Mitochondrial Cannabinoid Receptors in the Brain | 2018 | 2˙500˙000.00 | 2˙500˙000.00 |
93 | EXOGENESIS Syntenin-phosphatidic acid interaction in exosome biogenesis and cell-cell communication: a structure-function based approach | 2018 | 173˙076.00 | 173˙076.00 |
94 | OBERON An integrative strategy of testing systems for identification of EDs related to metabolic disorders | 2019 | 6˙745˙894.00 | 5˙978˙762.00 |
95 | JPCOFUND2 ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND) | 2019 | 33˙438˙899.00 | 11˙010˙911.00 |
96 | EJP RD European Joint Programme on Rare Diseases | 2019 | 100˙176˙062.00 | 55˙073˙831.00 |
97 | IMMCEPTION Nociception and sensory nerves as regulators of type 2 immunity and skin inflammation | 2019 | 1˙497˙441.00 | 1˙497˙441.00 |
98 | RIBOINFLAM Assessing the role of ribosomes and mRNA translation in shaping the inflammatory response | 2019 | 1˙499˙720.00 | 1˙499˙720.00 |
99 | HERA Integrating Environment and Health Research: a Vision for the EU | 2019 | 3˙097˙322.00 | 3˙097˙322.00 |
100 | GABASSEMBLY The role of GABAergic circuits in the orchestration of hippocampal neuronal assemblies | 2019 | 173˙076.00 | 173˙076.00 |
101 | NECESSITY NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients | 2019 | 15˙425˙020.00 | 8˙200˙000.00 |
102 | EFHHBBBMS Endothelial Hedgehog autocrine signaling at the Blood Brain Barrier controls inflammatory CentralNervous System lesion size and severity through Gas1 co-receptor modulation. | 2019 | 173˙076.00 | 173˙076.00 |
103 | WATCH Well-Aging and the Tanycytic Control of Health | 2019 | 9˙866˙250.00 | 9˙866˙250.00 |
104 | CARDIATEAM CARdiomyopathy in type 2 DIAbetes mellitus | 2019 | 12˙882˙500.00 | 6˙700˙000.00 |
105 | LUNG-BIM Induction of B cell immunity in the lung mucosa | 2019 | 184˙707.00 | 184˙707.00 |
106 | PML-THERAPY HARNESSING PML NUCLEAR BODIES FOR LEUKAEMIA THERAPY | 2019 | 2˙500˙000.00 | 2˙500˙000.00 |
107 | MECHANOMVP Mechanosensing and Mitral Valve Prolapse: from the Molecular Mechanisms to the Progression of the Disease | 2019 | 196˙707.00 | 196˙707.00 |
108 | SYNPATH Regulation of synaptic development and plasticity by molecular pathways linked to human evolution | 2019 | 1˙500˙000.00 | 1˙500˙000.00 |
109 | BREAKINGBARRIERS Targeting endothelial barriers to combat disease | 2019 | 2˙499˙969.00 | 2˙499˙969.00 |
110 | AB-DIRECT Antibiotic Distribution and Recovery in Tissue | 2019 | 3˙789˙717.00 | 3˙429˙217.00 |
111 | ADMEHE Mental health advocacy: Reassessing the history of mental health organizations in the second half of the twentieth century | 2019 | 185˙076.00 | 185˙076.00 |
112 | REMAKIN REstoring myocardial repair capacity via the modulation of MAcrophage-mediated cytoKINe secretion. | 2019 | 196˙707.00 | 196˙707.00 |
113 | STOPIG Translating fundamental insights in podocyte metabolism and cell cycle regulation: development of a new treatment for Stopping crescentic Immune Glomerulonephritis | 2019 | 150˙000.00 | 150˙000.00 |
114 | LABRHYTHMS Language and Brain Rhythms | 2019 | 184˙707.00 | 184˙707.00 |
115 | INVADERS Mucus-Penetrating Microbiota: Characterization, Mechanism and Therapeutic in Metabolic Disease | 2019 | 1˙850˙000.00 | 1˙850˙000.00 |
116 | HEPCAN A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 | 0.00 | 150˙000.00 |
117 | MIR-IBD Fecal miRNAs, new mediators of host-microbiota interaction in Inflammatory Bowel Disease | 2019 | 196˙707.00 | 196˙707.00 |
118 | METABOSENS Metabolic integration by nutrient SENSing | 2019 | 1˙999˙391.00 | 1˙999˙391.00 |
119 | IP-CURE-B Immune profiling to guide host-directed interventions to cure HBV infections | 2020 | 14˙943˙030.00 | 9˙983˙029.00 |
120 | FAIR FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA | 2020 | 10˙162˙903.00 | 10˙162˙903.00 |
121 | PREMSTEM Brain injury in the premature born infant: stem cell regeneration research network | 2020 | 10˙708˙285.00 | 8˙999˙620.00 |
122 | MININO Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility | 2020 | 6˙487˙770.00 | 6˙487˙770.00 |
123 | HUGODECA Human Gonad Developmental Cell Atlas | 2020 | 4˙822˙198.00 | 4˙822˙197.00 |
124 | THERALYMPH Gene Therapy to restore lymphatic flow lymphedema | 2020 | 8˙064˙946.00 | 8˙064˙946.00 |
125 | REMEDIA Impact of exposome on the course of lung diseases | 2020 | 11˙134˙616.00 | 11˙134˙616.00 |
126 | SUMIDENTITY Deconstructing the role of SUMO on chromatin in cell identity and tissue repair | 2020 | 2˙499˙995.00 | 2˙499˙995.00 |
127 | ENHPATHY Molecular basis of human enhanceropathies | 2020 | 3˙992˙397.00 | 3˙992˙397.00 |
128 | FLUATTACK Validation of a novel antiviral drug candidate against influenza | 2020 | 0.00 | 150˙000.00 |
129 | METEPIC P53-dependent Metabolic and Epigenetic Reprogramming in Carcinogenesis | 2020 | 196˙707.00 | 196˙707.00 |
130 | EVOMENS The evolution of menstruation in primates | 2020 | 1˙185˙250.00 | 1˙185˙250.00 |
131 | EDUC8 Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity | 2020 | 2˙100˙708.00 | 2˙100˙708.00 |
132 | EVEREST Extracellular Vesicles for Bone Regeneration – alternatives to Stem-cell Therapy | 2020 | 1˙499˙925.00 | 1˙499˙925.00 |
133 | ADDITIVES Exposure to ‘cocktails’ of food additives and chronic disease risk | 2020 | 2˙000˙000.00 | 2˙000˙000.00 |
134 | KISSANDSPITRHOPTRY Unravelling the secretion machinery for virulence factors in apicomplexan parasites | 2020 | 2˙496˙210.00 | 2˙496˙210.00 |
135 | ANTIBIOCLICKS BioInspired Clicked Siderophore-Antibiotics | 2020 | 2˙000˙000.00 | 2˙000˙000.00 |
136 | PMLINGAML Using PML nuclear body biology to identify potential AML treatment targets | 2020 | 184˙707.00 | 184˙707.00 |
137 | BICICLE Biophysics of circulating tumor cells, from single molecule to cell clusters | 2020 | 184˙707.00 | 184˙707.00 |
138 | HT4PD The role of the serotonin 5-HT4 receptor in motor and non-motor symptoms of Parkinson’s disease | 2021 | 295˙061.00 | 295˙061.00 |
139 | NICHEADAPT Deciphering the niche adaptations of a gut commensal involved in educating the host immune system | 2021 | 1˙999˙948.00 | 1˙999˙948.00 |
The Institution INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE has been involved also in the following Horizon 2020 projects.